{
    "clinical_study": {
        "@rank": "147878", 
        "arm_group": [
            {
                "arm_group_label": "Fermented Cinnamon Vine Powder", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators performed a 12-week, randomized, double-blind, placebo-controlled human\n      trial to evaluate the efficacy and safety of Fermented Cinnamon Vine Powde on decrement of\n      body fat. The investigators measured decrement of body fat parameters , including abdominal\n      fat, Body Fat Mass, LDL-C, HDL-C, Total Cholesterol and triglyceride, and monitored their\n      blood pressure."
        }, 
        "brief_title": "Efficacy and Safety of Fermented Cinnamon Vine Powder on Decrement of Body Fat", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females 19-55 years old\n\n          -  BMI(body mass index) \u2265 25 kg/m^2 or WC(Waist Circumference) \u2265 90(men), WC \u2265 85(women)\n\n          -  Able to give informed consent\n\n        Exclusion Criteria:\n\n          -  Significant variation in weight(more 10%) in the past 3 months\n\n          -  Allergic or hypersensitive to any of the ingredients in the test products\n\n          -  History of reaction to any of the test products or of gastrointestinal diseases such\n             as Crohn's disease or gastrointestinal surgery\n\n          -  History of alcohol or substance abuse\n\n          -  Participation in any other clinical trials within past 2 months\n\n          -  Laboratory test, medical or psychological conditions deemed by the investigators to\n             interfere with successful participation in the study\n\n          -  Pregnant or lactating women etc."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01734187", 
            "org_study_id": "CHEVIGEN-OBESE-DB"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fermented Cinnamon Vine Powder", 
                "description": "Fermented Cinnamon Vine Powder (30g/day)", 
                "intervention_name": "Fermented Cinnamon Vine Powder", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo (30g/day)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 26, 2012", 
        "location": {
            "contact": {
                "email": "soowan@jbnu.ac.kr", 
                "last_name": "Soo-Wan Chae, MD., PhD", 
                "phone": "82-63-250-2539"
            }, 
            "facility": {
                "address": {
                    "city": "Jeonju", 
                    "country": "Korea, Republic of", 
                    "state": "Jeollabuk-do", 
                    "zip": "560-822"
                }, 
                "name": "Clinical Trial Center for Functional Foods; Chonbuk National University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Abdominal Fat was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in abdominal Fat", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Body Fat Mass was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in Body Fat Mass", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01734187"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chonbuk National University Hospital", 
            "investigator_full_name": "Soo-Wan Chae", 
            "investigator_title": "Principal Investigator, Clinical Trial Center for Functional Foods", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "LDL-C(Low Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol)", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "HDL-cholesterol(High Density Lipoprotein - cholesterol) was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in HDL-Cholesterol(High Density Lipoprotein - Cholesterol)", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Total cholesterol was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in total cholesterol", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "Triglyceride was measured in study visit 1(0 week) and visit 3(12 week).", 
                "measure": "Changes in Triglycerides", 
                "safety_issue": "Yes", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Chonbuk National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chonbuk National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}